Clinical Trials Browser

Phase 1/2 × orantinib × Clear all

NCT00784290 2012-03-26

Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular